View Section: Company Analysis
SciClone Pharmaceuticals Rating
66
6600.HK stock rating score is 127/100. SciClone Pharmaceuticals is aViable Investment.
The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.
Eyestock Rating
Last update 21.05.2024
127/100
High score
Rating Breakdown
Profitability score
36
/25
Solvency score
45
/25
Efficiency score
42
/25
Stability score
3
/25
SciClone Pharmaceuticals (Holdings) Ltd Rewards and Warnings
The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.
Financial
Check
Value
Net Profit Margin
36 %
Earnings quality
125 %
Gross Margin
75 %
SciClone Pharmaceuticals (Holdings) Ltd's Historical Rating
How has the company's valuation changed in the past?
A quick analysis will help you understand how stable financial indicators are overall.
Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Discover High-rated Companies
View Section: Valuation